CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
about
Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions.CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment.
P2860
Q37226175-ACC46495-123C-4B62-837D-62236AED13D7Q38853651-133F2869-B00C-4E81-B19B-7A5396E008E9Q47254975-73B4E64F-6983-4780-A328-D8D255AD828BQ47570862-72ACD4BB-8EF9-4146-A3E1-17FBBC956935Q47664190-9DDB226F-02C3-4BD5-910C-8A5A41C06C3DQ53782592-9315A6C2-55A5-486F-B754-ECDAF5B8A9B3Q55017266-75A2FC6C-14BA-47E7-8363-8B7A28E39635
P2860
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
@en
type
label
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
@en
prefLabel
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
@en
P2860
P1476
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
@en
P2093
Valentina Franco
P2860
P304
P356
10.1517/17425255.2015.1053463
P407
P577
2015-06-03T00:00:00Z